Detalhe da pesquisa
1.
New synthetic molecules incorporated into polymeric micelles used for treatment against visceral leishmaniasis.
Cytokine
; 177: 156543, 2024 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-38373365
2.
Treatment using vanillin-derived synthetic molecules incorporated into polymeric micelles is effective against infection caused by Leishmania amazonensis species.
Exp Parasitol
; 260: 108743, 2024 Mar 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-38513973
3.
Exploring drug repositioning for leishmaniasis treatment: Ivermectin plus polymeric micelles induce immunological response and protection against tegumentary leishmaniasis.
Cytokine
; 164: 156143, 2023 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-36774730
4.
Immunization with recombinant LiHyp1 protein plus adjuvant is protective against tegumentary leishmaniasis.
Parasitol Res
; 122(12): 2917-2931, 2023 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-37768367
5.
Recombinant guanosine-5'-triphosphate (GTP)-binding protein associated with Poloxamer 407-based polymeric micelles protects against Leishmania infantum infection.
Cytokine
; 153: 155865, 2022 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-35339043
6.
Sensitive and specific serodiagnosis of tegumentary leishmaniasis using a new chimeric protein based on specific B-cell epitopes of Leishmania antigenic proteins.
Microb Pathog
; 162: 105341, 2022 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-34883228
7.
Evaluation from a B-cell epitope-based chimeric protein for the serodiagnosis of tegumentary and visceral leishmaniasis.
Microb Pathog
; 167: 105562, 2022 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-35513293
8.
Leishmania LiHyC protein is immunogenic and induces protection against visceral leishmaniasis.
Parasite Immunol
; 44(8): e12921, 2022 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-35437797
9.
Flau-A, a naphthoquinone derivative, is a promising therapeutic candidate against visceral leishmaniasis: A preliminary study.
Exp Parasitol
; 233: 108205, 2022 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-34968460
10.
Leishmania eukaryotic elongation Factor-1 beta protein is immunogenic and induces parasitological protection in mice against Leishmania infantum infection.
Microb Pathog
; 151: 104745, 2021 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-33485994
11.
Acarbose presents in vitro and in vivo antileishmanial activity against Leishmania infantum and is a promising therapeutic candidate against visceral leishmaniasis.
Med Microbiol Immunol
; 210(2-3): 133-147, 2021 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-33870453
12.
Diagnostic application of sensitive and specific phage-exposed epitopes for visceral leishmaniasis and human immunodeficiency virus coinfection.
Parasitology
; 148(13): 1706-1714, 2021 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-35060464
13.
Ivermectin presents effective and selective antileishmanial activity in vitro and in vivo against Leishmania infantum and is therapeutic against visceral leishmaniasis.
Exp Parasitol
; 221: 108059, 2021 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-33338468
14.
Digitoxigenin presents an effective and selective antileishmanial action against Leishmania infantum and is a potential therapeutic agent for visceral leishmaniasis.
Parasitol Res
; 120(1): 321-335, 2021 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-33191446
15.
Leishmania infantum amastin protein incorporated in distinct adjuvant systems induces protection against visceral leishmaniasis.
Cytokine
; 129: 155031, 2020 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-32062145
16.
Biotechnological applications from a Leishmania amastigote-specific hypothetical protein in the canine and human visceral leishmaniasis.
Microb Pathog
; 147: 104283, 2020 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-32485231
17.
Parasitological and immunological evaluation of a novel chemotherapeutic agent against visceral leishmaniasis.
Parasite Immunol
; 42(12): e12784, 2020 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-32772379
18.
A new Leishmania hypothetical protein can be used for accurate serodiagnosis of canine and human visceral leishmaniasis and as a potential prognostic marker for human disease.
Exp Parasitol
; 216: 107941, 2020 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-32622940
19.
Evaluation of the protective efficacy of a Leishmania protein associated with distinct adjuvants against visceral leishmaniasis and in vitro immunogenicity in human cells.
Parasitol Res
; 119(8): 2609-2622, 2020 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-32535734
20.
Recombinant Leishmania eukaryotic elongation factor-1 beta protein: A potential diagnostic antigen to detect tegumentary and visceral leishmaniasis in dogs and humans.
Microb Pathog
; 137: 103783, 2019 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-31600536